Media News

PanopticAI Secures Fundraising Co-Led by Alibaba Hong Kong Entrepreneurs Fund and Gobi Partners GBA to Digitise Remote Healthcare

HONG KONG, Jan. 30, 2023 /PRNewswire/ -- PanopticAI, Hong Kong's leading health and wellness monitoring startup, announced a deal closing on a seed-round funding co-led by Alibaba Hong Kong Entrepreneurs Fund (AEF) and Gobi Partners GBA (Gobi GBA), with participation from the HKUST Entrepreneurship Fund (E-Fund) and other renowned investors, marking a promising move in the digital healthcare industry....

WHO Goodwill Ambassador for Leprosy Elimination Has Audience with Pope Francis

Pope Supports Continued Efforts Against Leprosy, Reflects on Tragedy of War TOKYO, Jan. 27, 2023 /PRNewswire/ -- WHO Goodwill Ambassador for Leprosy Elimination Yohei Sasakawa had an audience with His Holiness Pope Francis at the Vatican on January 26, 2023, during which he requested the Pope's support in eliminating leprosy and the prejudice and discrimination associated with the disease....

SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs

SK bioscience shared a development history of the South Korea's first COVID-19 vaccine at the Riyadh Global Medical Biotechnology Summit 2023 (RGBMS 2023) in the Kingdom of Saudi Arabia(KSA) SK bioscience also explained a new global partnership model aiming to promote public health in developing countries SEOUL, South Korea, Jan....

Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results

Q4'22 consolidated revenue of KRW 965.5 billion and Q4'22 operating profit of KRW 312.8 billion. FY'22 consolidated revenue of KRW 3.00 trillion and FY'22 operating profit of KRW 983.6 billion. Strong growth momentum expected to continue with active expansions in capacity, geography, and portfolio. INCHEON, South Korea, Jan. 27, 2023 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), the world's...

Pfizer Launches AF Journey Website To Improve Atrial Fibrillation Health Literacy

KUALA LUMPUR, Malaysia, Jan. 27, 2023 /PRNewswire/ --  Pfizer Malaysia launched the new Atrial Fibrillation (AF) awareness website, www.afjourney.com.my, together with the National Heart Association of Malaysia (NHAM) and Malaysia Stroke Council (MSC). Atrial Fibrillation is an irregular heartbeat where the heart may not pump enough oxygen-rich blood out to the body.The website sheds light on AF and the...

Fosun International’s 2021 Annual Report Wins Gold Award at the 2022 International ARC Awards

HONG KONG, Jan. 27, 2023 /PRNewswire/ -- Winners of the 36th International ARC Awards have been announcement. The 2021 annual report of Fosun International Limited ("Fosun International" or the "Company", HKEX: 00656) won Gold Award in the "Traditional Annual Report" category of the 2022 International ARC Awards. The award commends Fosun International's annual report for its distinctive theme, clear business...

DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease

SALT LAKE CITY, Jan. 27, 2023 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing cell-based regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation...

Malaysian Society of Plastic and Reconstructive Surgery to host extensive networking and learning event for plastic surgeons and residents

The two-day symposium will have its core focus on cosmetic breast surgery, with two live surgical demonstrations. CPD points to be given to all participating surgeons. KUALA LUMPUR, Malaysia, Jan. 27, 2023 /PRNewswire/ --  The Malaysian Society for Plastic and Reconstructive Surgery (MSPRS) is set to host their first event for the year, "Cosmetic Breast Surgery - symposium and...

Rainwater Charitable Foundation Announces Fourth-Annual Rainwater Prize Winners for Brain Research

Honorees are recognized for their innovative scientific discoveries for neurodegenerative diseases FORT WORTH, Texas, Jan. 26, 2023 /PRNewswire/ -- The Rainwater Charitable Foundation, one of the largest independent funders of neurodegenerative disease research, today announced this year's recipients of the Rainwater Annual Prize for Outstanding Innovation in Neurodegenerative Disease Research and for...

Ascletis Announces IND Approval of Oral Viral Polymerase Inhibitor ASC10 for Monkeypox Indication by China NMPA

--Preclinical studies show that ASC10-A, the active metabolite of double prodrug ASC10, has potent antiviral activities against both monkeypox and SARS-CoV-2 viruses --Ascletis has received the Notice of Issuance from the United States Patent and Trademark Office (USPTO) for the patent application of ASC10 and its derivatives, and their uses to treat multiple virus infections HANGZHOU and SHAOXING,...